開始改善腸道健康
體驗Bioflor®的天然力量
Bioflor®全新研發益生菌 — 布拉酵母菌CNCM I-745 (Saccharomyces boulardii CNCM I-745)。與其他細菌及酵母益生菌不同，它源自獨特天然菌株，有助提升整體健康，功效更遠超傳統益生菌。Bioflor®獲科學及臨床數據實證，能為不同年齡人士提供專屬腸道健康解決方案2,3。
如有任何疑問
3P優勢
3P優勢 發揮更強效用
配對 (PAIR)
可與抗生素一同服用
保護 (PROTECT)
保護腸道菌叢
維護 (PRESERVE)
維持長期健康
Reference:
- Based on internal analysis by BIOCODEX using Quarterly data from the following sources: IQVIA MIDAS® Q1 2023 release (ATC: A7F) & IQVIA Consumer Health Customized Insights Q1 2023 release (OTC: 03F1/03D5) of quarterly sales data for the time period January 2022 to December 2022 (deduplicated for such period) reflecting estimates of real-world activity. Copyright IQVIA. All rights reserved.
- More MI, and Swidsinski. Clinical and experimental gastroenterology. 2015; 8: 237.
- McFarland, LV. Systematic review and meta-analysis of Saccharomyces boulardii in adult patients. World journal of gastroenterology: WJG. 2010; 16(18): 2202
AD-20240716-01